Bifidumbacterin, and topical application 5 doses 10 pcs

Pharmacotherapeutic group

Medical immunobiological drug – probiotic. ATX code: A07FA.

BIOLOGICAL PROPERTIES

Therapeutic properties of the drug are determined by live lyophilized bifidobacteria (Bifidobacterium bifidum) inherent in humans since birth with antagonistic activity against a wide range of pathogenic and conditionally pathogenic microorganisms. The high quantitative level of bifidobacteria in the preparation helps to normalize the intestinal microflora and thus improve the activity of the gastrointestinal tract, metabolic processes, and intestinal digestion, and increase nonspecific resistance of the organism.

Indications

Dysbacteriosis, Intestinal infections, Diarrhea, Colitis, Bloating, Inflammation of the female reproductive organs

Dysbacteriosis of the intestines of various etiologies.

In the complex therapy: intestinal dysfunctions of unspecified etiology; acute intestinal infections (dysentery, salmonellosis, escherichiosis, yersiniosis, rotavirus infection of unspecified etiology); patients with relapses after acute intestinal infections;

Chronic diseases of the digestive system with abnormal intestinal microflora;

Chronic diseases of the digestive system with abnormal intestinal microflora Children (including newborns and prematurely born) with pneumonia, sepsis and other purulent-infectious diseases; as well as those with anemia, hypotrophy, rickets to reduce complications and increase the effectiveness of the main treatment; Allergic diseases;

dysbiosis and inflammatory processes of the female genitalia (bacterial vaginosis, including in pregnant women, bacterial colpitis, and senile colpitis of hormonal nature).

To prevent dysbacteriosis when taking antibacterial drugs (including antibiotics), glucocorticosteroids, drugs that have a ulcerogenic effect on the gastrointestinal tract (including. NSAIDs);

In radiation and chemotherapy;

Stress and extremes; children of all ages with frequent illnesses;

Children with a history of pre-morbid conditions, those born prematurely or with signs of prematurity and those who received antibiotics in the early neonatal period. Children whose mothers have had severe toxemia, extragenital diseases, prolonged waterless period, lactastasis, cracked nipples and resumed breastfeeding after recovery from mastitis;

In infants when they are switched to artificial feeding and donor milk feeding at an early age.

In order to prevent mastitis for local mammary gland treatment in breastfeeding mothers of the “risk” group (in women with inverted flat nipple, decreased nipple erection, the presence of cracks).

Active ingredient

Bifidobacterium bifidum

Composition

the active substance – bifidobacteria – at least 500 million (5×10⁸ CFU)

excipient – lactose monohydrate – up to 0.85 g

How to take, the dosage

• children under 6 months, 1 sachet 2-3 times a day, from 2-3 days if necessary, the number of times the drug can be increased to 4-6 times a day,
• children over 6 months and up to 7 years of age.Children over 6 months and up to 3 years of age – 1 sachet 3-4 times a day,
• children from 3 to 7 years – 1 sachet 3-5 times a day,
• children over 7 years – 2 sachets 3-4 times a day,
• adults – 2 sachets 3-4 times a day.

The number of times the drug can be increased up to 6 times a day, if necessary.

The course of treatment 3-4 weeks. If necessary, the course of treatment can be repeated 2-3 times, each time in a month.

In acute cases of severe disease with severe dysbacteriosis the daily dose of the drug may be increased only by the doctor’s prescription. When using the drug in the complex treatment of acute intestinal infections the course of treatment is 7-10 days. For preventive purposes:

• children under 6 months 1 bag once a day,
• children over 6 months 1 bag 1-2 times a day,
• children from 3 years on 2 bags 1-2 times a day,
• adults on 2 bags 1-2 times a day.

Preventive course is carried out for 2-3 weeks 2-3 times a year. Bifidumbacterin taken with meals, if necessary, regardless of the meal. The drug is mixed with liquid foods, preferably fermented dairy products, newborns and infants – with breast milk or formula for infant feeding. The drug can be mixed with 30-50 ml of boiled room temperature water, which forms slightly opalescent whitish or grayish slurry. The resulting aqueous suspension should be drunk without achieving complete dissolution.

For topical use:

• for treatment of the mammary gland of a mother, 1 package of the drug is poured into 10-15 ml of boiled water at room temperature, soak the resulting suspension in a sterile swab and treat the nipple and areola area with it 20-30 minutes before each breastfeeding, the swab is left on the surface of the breast until the feeding, such treatment should be carried out at least 5 days, In gynecological practice – the contents of two sachets of the drug must be poured into 15-20 ml of boiled water at room temperature, abundantly saturate the resulting suspension of the sponge and put it in the vagina for 2-3 hours morning and evening, treatment course 8-10 days,
• in chronic bowel disease the drug can be given as a drug enema: Pour 2-3 sachets in 30-40 ml of boiled water at room temperature and using a balloon pear inject the resulting suspension into the rectum 30-40 minutes after a purifying enema, 1 time a day, the course of 10 days.

.

Interaction

Simultaneous administration of Bifidumbacterin with vitamins (especially group B) increases the effect of the drug. When taking antibiotics, the recommended interval between taking antibiotics and Bifidumbacterin is 3-4 hours.

Special Instructions

The drug does not affect the ability to drive vehicles and mechanisms.

Synopsis

Powder with a faint sour odor, white to light beige in color with flecks of yellow or beige.

Contraindications

Congenital lactase deficiency. Impaired glucose-galactose absorption.

Side effects

Not established.

Overdose

No cases of overdose were observed.

Pregnancy use

The drug is approved for use in women during pregnancy and breastfeeding. There are no special conditions for use.

Similarities

Bifidumbacterin forte